Rafferty Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Rafferty Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-186,528	Closed	-$13.4M	–	847
2018 Q4	$13.4M	Sell	186,528 -754,936	-80%	-$60.8M	0.29%	43
2018 Q3	$90.3M	Buy	941,464 +501,695	+114%	+$48.6M	1.4%	12
2018 Q2	$41.9M	Sell	439,769 -1,075,212	-71%	-$98.8M	0.63%	28
2018 Q1	$133M	Buy	1,514,981 +1,383,636	+1,053%	+$126M	1.97%	9
2017 Q4	$11.1M	Sell	131,345 -105,724	-45%	-$8.86M	0.19%	64
2017 Q3	$20.5M	Buy	237,069 +56,986	+32%	+$4.57M	0.46%	31
2017 Q2	$13.9M	Sell	180,083 -14,270	-7%	-$1.01M	0.4%	34
2017 Q1	$13.5M	Sell	194,353 -108,109	-36%	-$7.26M	0.3%	33
2016 Q4	$17.9M	Buy	302,462 +186,422	+161%	+$11.5M	0.82%	11
2016 Q3	$7.69M	Sell	116,040 -258,034	-69%	-$16M	0.28%	25
2016 Q2	$20.2M	Buy	374,074 +244,029	+188%	+$13.4M	1.37%	12
2016 Q1	$6.72M	Buy	+130,045	New	+$6.75M	0.37%	31
2015 Q3	–	Sell	-12,738	Closed	-$1.07M	–	616
2015 Q2	$1.07M	Buy	+12,738	New	+$991K	0.07%	204

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rafferty Asset Management's XBI Position: Q1 2019 in Review

Rafferty Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2019, closing a stake of 186,528 shares — an estimated $13.4M sold.

Rafferty Asset Management first reported a position in XBI in Q2 2015 and held it in 13 quarters. The position peaked at $133M in Q1 2018. 451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

Rafferty Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2019 after selling out during the quarter.
Rafferty Asset Management sold 186,528 State Street SPDR S&P Biotech ETF shares in Q1 2019, an estimated $13.4M.
Rafferty Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 13 quarters.
Rafferty Asset Management's State Street SPDR S&P Biotech ETF position peaked at $133M in Q1 2018.
451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on Rafferty Asset Management's 13F filing for Q1 2019, filed 15 May 2019.